Last deal

$4.6M

Amount

Venture - Series Unknown

Stage

04.04.2019

Date

5

all rounds

$8M

Total amount

General

About Company
Gradientech develops microfluidic products for analyzing cell behavior in response to signaling molecules.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2009

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The Swedish biotech company, Gradientech, offers products and solutions for both In Vitro Diagnostics and Research Use Only. Their microfluidic tools provide live imaging of cell behavior in response to defined concentration gradients, which helps in the formation of stable gradients of soluble substances in any type of 2D and 3D cell culture. Gradientech is developing QuickMIC®, an ultra-rapid system for antibiotic susceptibility testing of positive blood culture samples from sepsis patients. Their technology combines microfluidics with live cell imaging to study cell responses in a linear concentration gradient, and is suitable for many biological applications. Gradientech holds an ISO13485 certification.
Contacts